Listar por tema "Immunoglobulins, Intravenous"

Mostrando ítems 1-2 de 2

Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial

Bril, Vera; Hadden, Robert D.M.; Brannagan, Thomas H.; Bar, Michal; Chroni, Elisabeth; Rejdak, Konrad; Rivero, Alberto Daniel; Andersen, Henning; Latov, Norman; Levine, Todd; Pasnoor, Mamatha; Sacconi, Sabrina; Souayah, Nizar; Anderson-Smits, Colin; Duff, Kim; Greco, Erin; Hasan, Shabbir; Li, Zhaoyang; Yel, Leman; Ay, Hakan (Wiley, 2023-07-06)

Background and aims: ADVANCE-CIDP 1 evaluated facilitated subcutaneous immunoglobulin (fSCIG; human immunoglobulin G 10% with recombinant human hyaluronidase) efficacy and safety in preventing chronic inflammatory demyelinating ...
Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study

Verboon, Christine; Harbo, Thomas; Cornblath, David R.; Hughes, Richard A. C.; van Doorn, Pieter A.; Lunn, Michael P.; Gorson, Kenneth C.; Barroso, Fabio Adrián; Kuwabara, Satoshi; Galassi, Giuliana; Lehmann, Helmar C.; Kusunoki, Susumu; Reisin, Ricardo C.; Binda, Davide; Cavaletti, Guido; Jacobs, Bart C.; IGOS consortium; GOS consortium (BMJ Publishing Group, 2021-06-08)

Objective: To compare the disease course in patients with mild Guillain-Barré syndrome (GBS) who were treated with intravenous immunoglobulin (IVIg) or supportive care only. Methods: We selected patients from the ...

Buscar en DSpace